skip to Main Content
480.314.3070

Positron emission tomography (PET) as a predictive measure in patients with metastatic pancreatic cancer and normal CA19-9 levels at baseline

Ramanathan R.K., Korn R.L., Chiorean E.G., Liu H. & Von Hoff D.D. “Positron emission tomography (PET) as a predictive measure in patients with metastatic pancreatic cancer and normal CA19-9 levels at baseline.” Ann Oncol., 00: 1–2, (2016).

To read more click here

Back To Top